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Abstract
Defining the final size and geometry of engineered tissues
through precise control of the scalar and vector components of
tissue growth is a necessary benchmark for regenerative
medicine, but it has proved to be a significant challenge for
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tissue engineers. The growth plate cartilage that promotes
elongation of the long bones is a good model system for
studying morphogenetic mechanisms because cartilage is
composed of a single cell type, the chondrocyte; chondrocytes
are readily maintained in culture; and growth trajectory is
predominately in a single vector. In this cartilage, growth is
generated via a differentiation program that is spatially and
temporally regulated by an interconnected network composed of
long- and short-range signaling mechanisms that together result
in the formation of functionally distinct cellular zones. To facilitate
investigation of the mechanisms underlying anisotropic growth,
we developed an in vitro model of the growth plate cartilage by
using neonatal mouse growth plate chondrocytes encapsulated
in alginate hydrogel beads. In bead cultures, encapsulated
chondrocytes showed high viability, cartilage matrix deposition,
low levels of chondrocyte hypertrophy, and a progressive
increase in cell proliferation over 7 days in culture. Exogenous
factors were used to test functionality of the parathyroid-related
protein–Indian hedgehog (PTHrP-IHH) signaling interaction,
which is a crucial feedback loop for regulation of growth.
Consistent with in vivo observations, exogenous PTHrP
stimulated cell proliferation and inhibited hypertrophy, whereas
IHH signaling stimulated chondrocyte hypertrophy. Importantly,
the treatment of alginate bead cultures with IHH or thyroxine
resulted in formation of a discrete domain of hypertrophic cells
that mimics tissue architecture of native growth plate cartilage.
Together, these studies are the first demonstration of a tunable
in vitro system to model the signaling network interactions that
are required to induce zonal architecture in growth plate
chondrocytes, which could also potentially be used to grow




DURING EMBRYONIC AND postnatal skeletal development, the shape and
length of bones is determined by the activities of the growth plate cartilage.
Growth plate cartilage promotes elongation of long bones via regulation of
chondrocyte maturation that is reflected in morphologically and
functionally unique cellular domains.1 Toward the distal (epiphyseal) end
resides the resting (or reserve) zone that is composed of the least mature
chondrocytes.2 These resting zone chondrocytes are progressively recruited
into the proliferative zone, where cell cycle activation and changes in cell
morphology and cell organization result in expansion of isogenic columns
of chondrocytes along the axis of growth.3
As columns lengthen, chondrocytes at the proximal (metaphyseal) end of
the column withdraw from the cell cycle and increase in volume
(hypertrophy) in two steps that are characteristic of the prehypertrophic and
the hypertrophic chondrocytes.4,5 Growth is generated from chondrocyte
hypertrophy through increased cell mass and deposition of specialized
matrix.6 Hypertrophic chondrocytes are subsequently replaced by bone
through the process of endochondral ossification.7 Thus, continuous growth
over the two-decade span of human development requires tight coordination
between cell production in the resting and proliferative zones, and cartilage
loss in the hypertrophic zone.
Chondrocyte maturation in growth plate cartilage is coordinated by a
complex paracrine signaling network that is rooted in reciprocal interactions
between two major signal transduction pathways that include the secreted
ligands PTHrP (encoded by Pthlh), produced by periarticular resting
chondrocytes, and Indian hedgehog (IHH), produced by prehypertrophic
chondrocytes.8–11 In this context, PTHrP acts to maintain resting
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chondrocytes, and it stimulates the formation of proliferative
chondrocytes.9–12 In addition, PTHrP signaling represses hypertrophy, in
part, through the inhibition of IHH signal transduction.12–17 Conversely,
IHH induces hypertrophic differentiation in a PTHrP-independent manner
while promoting Pthlh expression in periarticular resting
chondrocytes.8,10,18–20 Therefore, crosstalk between PTHrP and IHH
paracrine signaling forms the core of a feedback circuit that maintains long-
term growth by balancing chondrocyte production with chondrocyte loss
through endochondral ossification.2,5
Despite a deep understanding of the regulatory pathways that regulate
growth, few options exist for clinical intervention in growth disorders.21–24
In vitro models of growth plate cartilage that reveal the network structure of
regulatory interactions would advance both drug discovery efforts and tissue
engineering solutions for growth disorders. One challenge is that
chondrocytes readily form cartilage in vitro, but they do not spontaneously
assemble into functional growth plates.25–28 Results using pellet cultures
generated from postnatal growth plate chondrocytes suggest that a growth
plate-like structure can be induced by the addition of exogenous factors. For
example, pellet cultures treated with the hormone thyroxine or the signaling
molecule Wnt5a form rudimentary chondrocyte columns and regionally
display morphological evidence of chondrocyte hypertrophy.29,30
Although these observations suggest that chondrocytes respond
appropriately to growth factor stimulation in vitro and that isolated
chondrocytes are competent to organize into columns, these studies did not
confirm formation of definitive growth plate structure through gene
expression or demonstrate that columns formed via known cell biological
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mechanisms. Therefore, it remains to be determined whether a limited
repertoire of signaling molecules is sufficient to establish growth plate
structure in vitro. Furthermore, pellet cultures significantly limit
mechanistic studies by affording minimal control over the spatial
distribution of growth factors and matrix structure. A culture system that
allows precise spatial and/or temporal manipulation of the cellular
microenvironment is needed to finely dissect the molecular mechanisms
that regulate vertebrate growth.
To establish an in vitro model of growth plate cartilage, we encapsulated
primary growth plate chondrocytes in beads composed of alginate hydrogel.
Alginate is a linear polysaccharide that forms hydrogels when crosslinked in
the presence of divalent cations.31 It is widely used in tissue engineering
applications because of its inherent nonfouling nature and ease of
functionalization of the alginate molecule, and because the pore size of
alginate hydrogels allows for the diffusion of waste out and nutrients and
growth factors into the tissue-engineered construct.31–40 Growth plate
chondrocytes that have been encapsulated in “semi-solid” alginate beads
maintain a rounded morphology.31–33 More recently, groups have utilized
alginate to inject growth plate chondrocytes into mice for long-term culture,
and they have even observed zonal arrangement and column formation.40,41
However, due to the complex nature of the in vivo culture environment, the
crucial factors for growth plate development were not elucidated.
In the current study, we describe a novel three-dimensional (3D) in vitro
culture model where chondrocytes encapsulated within alginate hydrogel
scaffolds display zonal arrangement of gene expression domains consistent
with growth plate cartilage architecture. In our culture system, chondrocytes
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display cell cycle properties and generate extracellular matrix consistent
with growth plate chondrocytes. Moreover, we show that chondrocyte
hypertrophy can be regulated by exogenous manipulation of PTHrP and IHH
signaling. Importantly, treatment of alginate bead cultures with soluble IHH
protein or thyroxine induces formation of a spatially distinct zone of
hypertrophy. Our results indicate that we have recapitulated the PTHrP/IHH
feedback loop in a minimal culture system and, thus, have developed a
viable model for studies of the genetic regulatory network that maintains the
growth plate cartilage, thereby promoting bone growth.
Materials and Methods
Materials
Unless otherwise indicated, chemicals and reagents were obtained from
Sigma Aldrich (St. Louis, MO), EMD (Darmstadt, Germany), or Thermo
Fisher Scientific (Waltham, MA); cell culture media from Gibco/Life
Technologies (Grand Island, NY); oligonucleotides from IDT (Coralville,
IA); and consumables from Thermo Fisher Scientific or VWR (Radnor, PA).
Growth factors were obtained from Sigma-Aldrich, EMD Calbiochem (San
Diego, CA), Tocris (Ellisville, MO), or R&D Systems, Inc. (Minneapolis,
MN).
Chondrocyte isolation
Neonatal Swiss Webster mice (Jackson Laboratories, Bar Harbor, ME) at
postnatal day 4 (P4, with P0 being the day of birth) were euthanized, and the
growth plate cartilage from both hind limbs was harvested into Hank's
balanced salt solution. Cartilage was transferred into complete medium that
was composed of Dulbecco's modified Eagle medium containing 10% fetal
6
bovine serum (Atlanta Biologicals, Flowery Branch, GA) and 1% glutamine-
penicillin-streptomycin. Collagenase was added to 0.25% (w/v), and the
cartilage was digested for 4 h in a passively humidified incubator at 37°C
and 8% CO2 and pipetted several times to break up remaining tissue.
Chondrocytes were pelleted by centrifugation at 125 g for 5 min by using a
Sorvall Legend RT centrifuge (Kendro Laboratories, Newtown CT) and
resuspended in Complete Medium. Cell density was quantified by using a
hemocytometer. Chondrocytes were maintained in the incubator until time
for alginate encapsulation. All procedures performed on animals were
consistent with regulatory agency policies and were approved by the
Institutional Care and Use Committee at the University of Nebraska
Medical Center.
Chondrocyte encapsulation in alginate
Sodium alginate powder (Pronova UP MVG, >60% guluronic acid, 200,000–
300,000 g/mol; NovaMatrix, Sandvika, Norway) was dissolved in sterile
phosphate-buffered saline (PBS) to a concentration of 1.5% (w/v), and the
solution was filtered sterilized by using 0.20 μm Rapid-Flow PES filters.
Growth plate chondrocytes were pelleted by centrifugation at 125 g for 5 
min and resuspended in an appropriate volume of alginate solution (to 8 × 
106 cells/mL) by gentle pipetting and vortexing. Homogenous alginate
beads were formed by using the basic “drop” method previously
described.34 Briefly, 10 μL of alginate-cell solution was drawn into a pipette
tip, and the tip was wiped with a Kimwipe® to ensure the alginate could
drop freely from the tip. The plunger was rapidly depressed to release a drop
of the cell suspension into 2 mL of crosslinking solution (50 mM CaCl2/140 
mM NaCl at 37°C) contained in a 24-well tissue culture dish from a height
of 2–3 inches. Only one bead was prepared in an individual well. After 2 
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min of crosslinking, beads were transferred to a well containing 2-mL of
Complete Medium for a maximum of 10 min and then washed in minimum
essential medium (MEM)-alpha medium without Phenol Red (α-MEM) for
a maximum of 10 min. After both washes, the bead was placed into cartilage
culture media (described later).
Culture conditions
Cartilage culture media were prepared by using previously described
methods4: α-MEM supplemented with 50 μL/mL GPS, β-glycerophosphate
(10 mM), and L(+) ascorbic acid (50 μg/mL). In addition, dexamethasone
(1 nM), proline (1 mg/mL), 1% antioxidant (Sigma Aldrich), sodium
pyruvate (1 mM), 1% nonessential amino acids (Gibco), and 1% Insulin-
Transferrin-Selenium +3 media supplement (ITS +3; Sigma Aldrich) were
added. In some cultures, parathyroid hormone 1–34 (PTH1–34), IHH,
purmorphamine (PMA), bone morphogenetic protein-4 (BMP4), or
thyroxine (T4) was added to the media at the concentrations indicated in the
text. Beads were cultured in a 48-well plate in a humidified incubator at
37°C and 8% CO2 for a maximum of 7 days, with medium changes every
day.
Evaluation of viability
Viability of encapsulated chondrocytes was determined by using a
Live/Dead Cell Viability kit (Invitrogen). Briefly, after culture, beads were
incubated in PBS containing 2 μM Calcein AM/4 μM ethidium homodimer-
1 for 30 min in the dark, washed in several changes of PBS and the
fluorescence signal of live (green) and dead (red) cells was imaged by using
a Leica DMI6000B inverted microscope. Live and dead cell counts were
quantified from the resulting images by using a basic ImageJ macro
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(Supplementary Data; Supplementary Data are available online at
www.liebertpub.com/tea) to calculate percent viability.
Immunofluorescence imaging
For immunofluorescence analysis, all reagent and wash solutions contained
2 mM CaCl2 to maintain crosslinking of alginate. Beads were fixed with 4%
paraformaldehyde (PFA) for 20 min, permeabilized with TBST (0.1% Triton
X-100/15-mM Tris-HCl/136-mM NaCl, pH 7.6), and blocked for 2 h with
10% heat-inactivated sheep serum (HISS; Sigma Aldrich) in TBST.
Subsequently, the beads were incubated with gentle rocking at 4°C in either
rabbit-anti-Collagen VI (1:500; Abcam, Cambridge, United Kingdom) or
rabbit-anti-Collagen IV (1:500; Abcam) primary antibody in 2%
HISS/TBST overnight. The beads were then incubated in a secondary anti-
mouse AlexaFluor 647 antibody (1:1000; Jackson Laboratories) and
phalloidin-labeled AlexaFluor 488 (1:100; Invitrogen) for 2 h in 2%
HISS/TBST. After washing for 3 × 5 min in TBST, the beads were mounted
with Prolong Gold antifade reagent with DAPI (Invitrogen) on a glass
microscope slide with a coverslip. Images were obtained on a Leica
DMI6000B inverted microscope or a Zeiss 710 laser scanning confocal
microscope. For confocal microscopy, optical sections were collected at 1.8-
μm intervals for between 15 and 25 sections (total depth of 30–40-μm), with
line averaging = 2, scan speed = 4 or 5, and resolution = 1024 × 1024).
Transcript expression analysis
For each experimental condition, four beads were depolymerized in 50 μL of
50 mM ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA) and
chondrocytes were recovered by centrifugation. RNA was isolated from
cells by using the NucleoSpin® RNA Plus kit (Thermo Fisher) according to
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the manufacturer's instructions and quantified by using a Thermo Fisher
Scientific NanoDropOne spectrophotometer. cDNA was synthesized by
using Superscript IV (Thermo Fisher) according to the manufacturer's
instructions and analyzed by a digital droplet polymerase chain reaction
(ddPCR; Bio-Rad Laboratories, Inc., Pleasanton CA). Thermal cycling
conditions were 95°C for 5 min, 40 amplification cycles (95°C for 30 s and
60°C for 30 s), and a final signal stabilization step (4°C for 5 min, 90°C for
5 min). The transcript count of each gene of interest was normalized with a
geometric average of transcript counts of three normalization control
transcripts: actin, RPL13a, and HPRT. Data from this analysis are reported
as fold change in the geometric mean ± standard error of mean (SEM) over
the transcript count of the nontreated control, and significance was
calculated by using two-way analysis of variance (ANOVA) analysis using
Prism software (GraphPad Software, Inc, La Jolla, CA). A full list of primer
sequences and gene accession numbers used to generate primers is included
in Supplementary Table S1.42–48
Flow cytometry
Fluorescence-activated cell sorting (FACS) was used to analyze cell cycle
progression in cultured chondrocytes. Alginate beads were dissociated in
200 μL of 50 mM EDTA for 5 min. Cells were washed with PBS and
centrifuged at 125 g for 5 min. The cell pellet was resuspended in 200-μL of
PBS and fixed by adding 2.8 mL of ice-cold 90% ethanol dropwise while
vortexing. Fixed cells were stored at −20°C for a maximum of 7 days. For
cell cycle analysis, DNA in fixed cells was stained with 0.05 mg/mL of
propidium iodide in Telford's reagent (33.62 μg/mL EDTA, 26.8 μg/mL
RNAse A at 93 U/mg, and 0.1% Triton X-100) for 1 h at 4°C in the dark.
Labeled suspensions of cells were filtered through 5-mL filter-cap
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polypropylene Falcon tubes (Corning Labs, Tamaulipas, Mexico) and were
then immediately analyzed on a BD FACSCaliber 2 flow cytometer (BD,
Franklin Lakes, NJ). The resulting cell cycle data were represented as
stacked bar graphs of the geometric mean ± SEM of percentage of cells in
each phase of the cell cycle, and significance was calculated by using a two-
way ANOVA using GraphPad Prism software.
In situ hybridization
For fluorescence in situ hybridization (FISH) analysis of gene expression in
cell cultures, whole alginate beads containing chondrocytes were fixed in
4% PFA in TBS containing 5 mM CaCl2 overnight at 4°C. To maintain
structural integrity of the sample, beads were infiltrated with 37.5:1 40%
acrylamide (JT Baker, Center Valley, PA) overnight at 4°C and the
acrylamide was polymerized by using 10% ammonium persulfate (10 
μL/mL acrylamide) and TEMED (1 μL/mL acrylamide). Polymerized
samples were subsequently incubated in 30% sucrose overnight at 4°C
before embedding in Tissue-Tek Optimum Cutting Temperature embedding
medium and freezing on dry ice. Sections (60 μm) were collected on glass
microscope slides, and FISH was performed by using fluorescein-labeled
RNA probes for collagen2a1 (ColII) and collagen 10a1 (ColX), as
previously described.49 Slides were mounted by using Prolong Gold
antifade reagent with DAPI (Life Technologies), and images were obtained
on a Leica DMI6000B inverted microscope. The images presented in this
article are montages that were assembled by tiling and stitching images
from several optical planes as a z-stack (10-μm width between individual
slices in the z-stack, 3 total slices per z-stack, total width of the z-stack
equaling 20 μm) to visualize the entire section of the bead for downstream
quantification. To quantify cell counts, we used a batch processing analysis
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in Image J using a macro-programmed in-house using FIJI software
(http://fiji.sc/) to quantify the number of cells expressing the respective
gene (for macro, see Supplementary Data). Typically, each image yielded
cell counts of ∼1000 and the data for each experimental condition were
derived from ∼10,000 cell counts. The fraction of cells expressing a given
gene was determined by dividing the number of cells expressing the gene by
the number of DAPI-positive nuclei observed in the section. The ColX:ColII
ratio was calculated as the geometric mean of the ColX:DAPI ratio for each
replicate divided by the geometric mean of the Col2:DAPI ratio for each
replicate (n = 3 or 4 sections for each replicate). The ratio is reported as the
geometric mean of the ColX:ColII ratio for each replicate ± SEM. To
determine statistical significance, a Student's t-test was used. To determine
whether a given treatment had significant overall effects on hypertrophy,
datasets from different time points were pooled into treated or untreated
groups and compared by using a paired Wilcox signed-rank test.
Results
Alginate culture maintains the growth plate cartilage phenotype
The objective of this study was to investigate the use of alginate hydrogels
as 3D scaffolds for the development of an in vitro growth plate model. As a
starting point, we analyzed the short-term cellular response of mouse
chondrocytes to encapsulation within 1.5% alginate hydrogels for a
maximum of 7 days. The culture conditions used resulted in cell viability
greater than 90% on days 0, 1, 4, and 7 (Fig. 1A and Supplementary Table
S2). Individual chondrocytes progressively elaborated a pericellular matrix,
as evidenced by extracellular domains of collagen IV and collagen VI,
during the 7-day culture period (Fig. 1B). Since spontaneous
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dedifferentiation and hypertrophy are common problems in chondrocyte
cultures, we next assessed chondrocyte differentiation via quantitative
ddPCR analysis of gene expression. Chondrocytes in our alginate bead
cultures express high levels of ColII (Fig. 2A), low levels of the fibroblast
marker collagen1a1 (ColI, Fig. 2B), and maintain a stable ratio of ColII:ColI
gene expression (Fig. 2C), a measure commonly used to assess chondrocyte
dedifferentiation. Although the ColII:ColI ratio did not significantly change
over time, ColX expression, a marker of chondrocyte hypertrophy,
decreased rapidly and significantly (Fig. 2D).
View larger version
FIG. 1. Culture in alginate hydrogel promotes chondrocyte growth.
(A) Invitrogen Live/Dead assay to determine chondrocyte viability for
at least a week of alginate culture. Evident cell proliferation is noticed
over time, but low amounts of dead cells are seen at all time points
(n = 3). (B) Immunofluorescence assay demonstrating the formation of pericellular
matrix in alginate culture using antibodies against Collagen IV (left) and Collagen VI
(right). Freshly isolated chondrocytes lack ECM staining, but they produce de novo
ECM after 1 day in alginate culture. On day 4 (right), a secondary ECM structure is
observed resembling territorial matrices (n = 4). Arrowheads in (B) indicate the
position of the cell membrane. Scale bar is 150 μm in (A) and 10 μm in (B).
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View larger version
FIG. 2. Culture in alginate hydrogel restrains cartilage
differentiation. Gene expression analysis of alginate cultures using
ddPCR (n = 4) to count mRNA transcripts of Collagen 2 (A),
Collagen 1 (B), Collagen X (D), and PTHrP (F). Values are reported as fold change in
gene expression relative to day 1. (C) Ratio of mRNA transcript counts of Collagen 2
and Collagen 1. (E) Propidium iodide cell cycle analysis by FACS to quantify
percentage of cells in S phase (DNA synthesis for cell proliferation/growth). Alginate
cultures tend to increase the number of proliferating cells over time, compared with D0
and D1 (n = 3). *p < 0.05, **p < 0.01. ddPCR, digital droplet polymerase chain
reaction; FACS, fluorescence-activated cell sorting; PTHrP, parathyroid-related
protein.
We also noted that cell density within the beads increased over time (Fig.
1A) and many of the initial single cells become doublets in our cultures
(data not shown), two observations that are consistent with cell
proliferation. Therefore, we performed cell cycle analysis of our cultures by
using flow cytometry (FACS). FACS analysis revealed two populations of
chondrocytes in our cultures that were distinguished by both forward and
side scatter measures of cell size, and, thus, will be referred to as “larger”
and “smaller” chondrocyte populations (Supplementary Fig. S1). Smaller
chondrocytes constituted less than 10% of the chondrocytes recovered from
the beads and were associated with the only observable instances of sub-G1
peaks. In related experiments, we have observed that these small cells
remain in the G1 phase of the cell cycle regardless of condition or treatment
(data not shown), whereas larger cells are growth factor responsive (see
below). Thus, only the larger, growth factor-responsive cells were included
in the reported cell cycle analysis.
In this population of larger chondrocytes, FACS analysis revealed that only
5–7% of chondrocytes were in S phase at the initiation of alginate culture
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(Fig. 2E), whereas 15–20% of cells were in S phase in embryonic growth
plate cartilage.50 However, during 7 days of culture within the alginate
hydrogel beads, we observed a statistically significant increase in the
percentage of cells in S phase that approached the level reported in vivo
(Fig. 2E). Since PTHrP has been shown to both inhibit hypertrophy and
promote cell proliferation in cartilage,16,17 we next asked whether PTHrP
was expressed by chondrocytes in our alginate culture. ddPCR analysis
confirmed a significant upregulation of PTHrP expression over 7 days of
culture (Fig. 2F). Taken together, these data suggest that our minimal
culture conditions are sufficient to maintain the growth plate chondrocyte
phenotype in vitro.
PTH1–34 treatment promotes cell proliferation in alginate bead
culture
Given the correlations between PTHrP expression, cell proliferation, and
chondrocyte differentiation, we next asked whether the stimulation of
PTHrP signaling could further enhance cell proliferation and
chondrogenesis. We cultured chondrocytes in the presence of recombinant
human PTH1–34, a 34-amino-acid peptide derived from the N-terminus of
the parathyroid hormone that has been shown to activate the same receptor
and downstream signal transduction pathways as the natural ligand PTHrP
in chondrocytes.9,17 FACS analysis showed that 1 day treatment with
PTH1–34 increased the fraction of cells in S phase as compared with
untreated controls, whereas no significant difference was observed after 4
days of treatment even when culture medium and factors were replaced
every day (Fig. 3A). It should be noted that the fraction of S-phase cells in
PTH1–34 stimulated cultures was identical after 1- and 4 days of treatment
(compare 100 nM PTH on day 1 and 4). Therefore, the apparent
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desensitization to PTH1–34 treatment results from the increase in cell cycle
activation over time in untreated cultures (compare 0 nM PTH on day 1 and
day 4). Thus, exogenous stimulation of PTHrP signaling enhances
chondrocyte cell proliferation in the short term, but it does not appear to
have long-term benefits.
View larger version
FIG. 3. Treatment with PTH1–34 accelerates the chondrocyte
response to alginate bead culture. (A) Propidium iodide cell cycle
analysis by FACS to quantify percentage of cells in S phase (DNA
synthesis for cell proliferation/growth). PTH treatment on day 1
stimulates proliferation similar to levels that are typically seen in day 4 cultures.
However, 4 days of PTH treatment has little effect (n = 4). (B–E) Gene expression
analysis was performed on PTH-treated alginate cultures with ddPCR to count mRNA
transcripts. On day 1 (left), PTHrP signaling inhibits expression of Collagen X (B), IHH
(C), and PTHrP (E), but not Collagen 2 (D). After 4 days of culture (right), the effects of
PTHrP on gene expression are greatly attenuated (n = 3). *p < 0.05, **p < 0.01, and
***p < 0.001. IHH, Indian hedgehog; N.S., not significant.
In addition to stimulating cell cycle progression, PTH1–34 also significantly
reduced the expression of ColX (hypertrophic chondroctyes, Fig. 3B) and
Ihh (prehypertrophic chondrocytes, Fig. 3C), as well as endogenous
expression of PTHrP after 1 day of treatment as compared with control
cultures (Fig. 3E). One interesting observation was that PTH1–34 treatment
continued to repress ColX expression after 4 days of treatment, whereas the
expression of other genes (i.e., Ihh and PTHrP) had already returned to the
level of untreated cultures. Therefore, we decided to validate the ddPCR
results by analyzing gene expression at single-cell resolution by using FISH.
In situ hybridization in alginate beads is difficult because the elevated
hybridization temperatures, denaturing conditions, and metal ion chelation
of hybridization buffers promote depolymerization of the alginate scaffold.
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To address this issue, we devised a novel tissue processing protocol in
which alginate beads are stabilized before cryo-embedding by infiltration
with acrylamide and induction of polymerization with ammonium
persulfate.
Using this method, we were able to carry out FISH on slides without
disrupting the integrity of bead architecture, which allowed the spatial
relationships between cells in our culture to be accurately determined. We
visualized gene expression in each cell with fluorescence microscopy (Fig.
4A, left), and quantified the total cell number (DAPI), as well as the number
of hypertrophic chondrocytes (ColX) and immature chondrocytes (ColII) by
using an object-counting macro in ImageJ (see Supplementary Data). These
values were used to calculate the hypertrophic index (ratio of ColX-positive
cells:ColII-positive cells) that describes the state of chondrocyte maturation
in regions of the alginate beads. Using this approach, we found that PTH1–
34 treatment reduced the hypertrophic index after both 1-day and 4-day
treatments (Fig. 4B). Although the downward trend on each day was not
statistically significant, the overall effect of PTH1–34 treatment across days
was a significant reduction in hypertrophic index. Thus, together, in situ
hybridization image analysis and ddPCR transcript quantification




FIG. 4. Visualizing chondrocyte gene expression in alginate bead
culture. (A) Fluorescent images generated by using our improved
protocol exploiting acrylamide embedding of fixed beads in
conjunction with fluorescent in situ hybridization (FISH) to visualize cells that highly
express Collagen II (left) and Collagen X (right) as a cell-by-cell measure of
hypertrophic differentiation. Images are analyzed via a fully automated macro in
ImageJ to quantify the percentage of cells expressing each gene relative to a nuclear
DAPI stain. Ratio of these percentages was calculated (ColX/Col2) to yield a
hypertrophic index (refer to Methods for more details). (B) Quantification of
hypertrophic index in PTH1–34 treated and untreated cultures (n = 3). PTH1–34,
parathyroid hormone 1–34.
Activation of IHH signaling induces chondrocyte hypertrophy in
alginate bead culture
In vivo, IHH signaling both promotes chondrocyte hypertrophy8,10,15 and
activates PTHrP gene expression,2,5 which antagonizes chondrocyte
maturation, including hypertrophy.14–17 Therefore, we next asked which
effect would dominate after exogenous activation of IHH signaling in
alginate culture. To answer this question, we used three known activators of
IHH signaling: PMA, a commonly used agonist of Smoothened, the
signaling component of the hedgehog receptor complex51; thyroxine, a
hormone that activates IHH expression in chondrocytes52,53; and BMP4,
which is known to upregulate IHH expression.12,54 At all time points
analyzed, IHH-activating agents increased the hypertrophic index, as
determined by FISH analysis (Fig. 5A, B) and increased the fraction of large
cells as determined by FACS analysis (Supplementary Fig. S2). After
pooling data from different time points, it was determined that overall, 1
and 5 ng/mL BMP4, 0.5 μg/mL PMA, and 500 ng/mL thyroxine each
significantly increased the hypertrophic index of bead cultures. In addition,
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both PMA and thyroxine maintain the proportion of large (growth factor
responsive) cells in alginate culture (Fig. 5C, D). Given that direct
activation of IHH signaling by the Smoothened agonist PMA increased the
hypertrophic index to a greater extent than the indirect activators thyroxine
and BMP4, we next asked whether recombinant IHH protein could similarly
induce chondrocyte hypertrophy. As expected, hypertrophy was induced by
IHH, as determined by the ColX:ColII ratio (Fig. 5A, B). However, the
induction of hypertrophy (ColX-positive cells) was observed exclusively in
cells near the bead surface, appearing as a ring illuminating the bead edges
when analyzed by epifluorescence microscopy (Fig. 6A). Conversely, ColII-
positive cells were enriched within core of the bead (Fig. 6A, quantification
in Fig. 6B, C). Interestingly, treatment with thyroxine, but not PMA, also
induced the formation of a peripheral ColX expression domain (Fig. 6D).
These data demonstrate regionalization of chondrocytes within alginate
bead cultures into a layer of hypertrophic-zone-like cells on the bead
periphery that surrounds a core of less mature chondrocytes. To our
knowledge, this is the first example of zonal chondrocyte organization in a
tissue-engineered cartilage construct in vitro.
View larger version
FIG. 5. Induction of hypertrophy after exogenous activation of IHH
signaling. (A, B) Analysis of FISH-derived images to calculate the
extent of hypertrophy in alginate cultures treated with thyroxine (10,
500 ng/mL), BMP4 (1, 5 ng/mL), PMA (0.5, 5 μg/mL), and IHH (100 ng/mL) for a single
day (A) and for 4 days in culture (B) (n = 3). In panel B, PMA 20 day 4, the error bar is
much larger than the rest of the data points and, therefore, is clipped by the axis. (C,
D) Propidium iodide analysis of stimulated bead cultures was performed to quantify
the percentage of cells in S phase (n = 3) on days 1 (C) and 4 (D). *p < 0.05, **p < 
0.01, and ***p < 0.001. BMP4, bone morphogenetic protein-4; PMA, purmorphamine.
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View larger version
FIG. 6. IHH treatment in alginate bead culture is sufficient to
establish chondrocyte zonal arrangement. (A) FISH (top) was used to
visualize ColX-expressing (left) and ColII-expressing (right) cells in
100 ng/mL IHH-treated cultures. White dotted lines delineate the
observed zones of predominant expression. Red dotted lines
delineate the outer boundary of the bead. Beads form a ColX-enriched ring (outer
portion) surrounding a ColII-enriched core (inner portion). DAPI (middle) is shown on
the right to demonstrate that cells are still evenly dispersed in hydrogel culture after 4
days, aside from isogenic groups, (n = 3). (B) Counts of ColII-expressing and ColX-
expressing cells (divided by the count of DAPI-positive nuclei in each FISH image),
stacked in a bar graph to illustrate the relative predominance of hypertrophic versus
nonhypertrophic chondrocytes in different domains of the IHH-treated alginate beads.
(C) Hypertrophic indexes of different domains of the IHH-treated alginate beads. (D)
FISH was used to visualize ColX-expressing (left) and total (right) chondrocytes in
alginate cultures treated with 10 ng/mL thyroxine.
Discussion
In children, growth plate cartilage is crucial to skeletal morphogenesis.
Defects in growth plate function due to genetics (incidence of
chondrodysplasia—1 in 5000 births), metabolic disease, radiation and
chemotherapy, and high-impact fractures affect skeletal growth, which can
lead to deformities, growth arrest, or structural instability of developing
long bones.22–24 However, an incomplete understanding of the molecular
and cellular processes that produce growth has resulted in few clinical
options to treat growth defects and has severely limited advances in tissue
engineering and regenerative strategies to replace damaged or diseased
tissue.22–24 Although genetic models have identified many important
molecules that regulate cartilage morphogenesis, a deeper mechanistic
understanding of growth regulation in vertebrates has been confounded by
the lack of tools for precise and combinatorial genetic manipulation that is
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needed to determine mechanism. In vitro models offer the potential to
simultaneously regulate multiple secreted, matrix, and mechanical factors in
space and time.55–58 Here, we describe the development of a 3D
chondrocyte culture system by using mouse neonatal growth plate
chondrocytes encapsulated in an alginate hydrogel to investigate the
mechanisms underlying growth plate formation, regulation, and growth
disorders.
3D alginate culture favors immature chondrocytes
For many tissues, two-dimensional cultures are sufficient to preserve cell
phenotypes and cell-specific responses to growth factor signaling. However,
in the case of growth plate cartilage, monolayer cultures promote
dedifferentiation of chondrocytes, abnormal gene expression profiles, and
inappropriate responses to signaling factors.59–62 The 3D culture of
chondrocytes in pellets, micromass, or artificial scaffolds has been shown to
maintain the chondrogenic phenotype.27–31,61,62 Although pellet cultures
have been induced to generate a growth plate-like architecture, the difficulty
of manipulating these cultures to generate regional differences in signaling
factor concentrations or matrix composition inspired us to explore culture
models in which chondrocytes are encapsulated in hydrogel scaffolds that
have defined composition. The choice of scaffold is potentially important,
since a physical interaction of scaffold materials with cells and growth
factors might significantly alter outcomes of these models. Therefore, we
chose alginate as a scaffold material because the low cell adhesion, limited
protein binding, and minimal cell toxicity of this material render alginate a
“blank slate” for the introduction of defined signaling and matrix factors.
The many advantages of alginate also include mild gelation conditions, fluid
diffusion of nutrients and wastes into and out of the construct, and
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accessible functional groups for modifications.39 For these reasons, many
cell types, including articular chondrocytes,28 have been successfully
cultured in alginate gels.
Our basal culture conditions display high viability and extracellular matrix
deposition that are consistent with previous reports,27 which suggests that
the basal culture conditions are permissive for chondrogenesis. However,
unlike previously described growth plate cartilage cultures, we observed a
rapid and significant decrease in chondrocyte hypertrophy and a
concomitant increase in cell proliferation during 7 days in culture. These
findings are important because the induction of hypertrophy and cell cycle
exit are common observations in monolayer and micromass culture of
chondrocytes.25,26 In these contexts, hypertrophy is often accompanied by
expression of IHH and BMPs, and, thus, it has been assumed that isolated
growth plate chondrocytes are unable to maintain expression of factors that
are required to repress chondrocyte maturation.54 By contrast, our results
demonstrate that these alginate culture conditions promote the maintenance
of proliferating and growth factor-responsive chondrocytes that exhibit
minimal hypertrophy. Although the mechanism remains to be defined,
endogenous production of PTHrP might underlie preservation of the
chondrocyte phenotype in alginate since PTHrP expression continued to
increase during the 7 day culture period and the addition of exogenous
PTH1–34 inhibited the expression of both ColX and IHH, transcriptional
markers of chondrocyte hypertrophy. These data strongly suggest that
resting/proliferative chondrocytes, not hypertrophic chondrocytes, are the
default maturation state in our alginate cultures.
PTHrP signaling is the primary driver of cell proliferation in alginate
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culture
Although endogenous PTHrP production likely plays an important role in
the maintenance of chondrogenesis, PTHrP expression in our culture system
increases at a rate that is probably suboptimal for chondrocyte cultures. For
example, during 7 days in basal medium, our cultures display increased cell
cycle entry from ∼5% of cells in S phase at day 0 to ∼15% by day 7. In
contrast, ∼20% of resting and proliferative chondrocytes are in S phase in
embryonic growth plate cartilage.50 However, after only 1 day of treatment
with PTH1–34, cell proliferation within our cultures was restored to in vivo
levels in our cultures. PTH1–34 stimulation of cell proliferation occurs
concomitant with a loss of IHH expression, suggesting that PTHrP signaling
alone is the primary driver of cell proliferation in these cultures.
The apparent primacy of PTHrP signaling is surprising given the genetic
evidence for roles of IHH, Wnt5a, and Wnt5b in cell cycle control.12,20,50
This paradox could be explained if these growth factors regulate PTHrP
expression or if PTH1–34 induces the expression of additional endogenous
growth factors. The in vivo observation of 20% S phase cells likely
represents a limit to the rate of proliferation in heterogeneous chondrocyte
populations, since this rate was not exceeded by using lower or higher
concentrations of PTH1-34 (data not shown). Together, our data suggest that
the establishment of PTHrP signaling is a crucial step to restore normal cell
proliferation levels in growth plate chondrocyte cultures. However, one
potential challenge to using PTH1–34 in long-term cultures is the potential
for desensitization of the PTHrP signaling pathway (Fig. 3), which could
alter the cell proliferation rate and possibly lead to the induction of cell
hypertrophy. Results presented here suggest that chronic treatment is not
detrimental to cultures since continuous stimulation with PTH1–34
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maintained maximum levels of cell proliferation and minimum levels of
ColX and Ihh expression for at least 7 days in our cultures. Given these
results, we suggest that PTHrP signaling plays a crucial, yet
underappreciated role in maintaining cultures of growth plate chondrocytes.
IHH signaling establishes a hypertrophic zone in alginate culture
PTH1–34 stimulation of the cell cycle and repression of hypertrophy (Fig.
3A, B) demonstrate that PTHrP pathway functions are maintained in
chondrocytes within our alginate cultures.3,6 Likewise, our data show that
functions of the IHH signaling pathway are also preserved in these cultures.
Specifically, the activation of IHH signaling either directly (IHH or PMA)
or indirectly via BMP signaling (thyroxine or BMP4) increased the
proportion of ColX-expressing chondrocytes in bead cultures (Fig. 5A, B).
Induction of chondrocyte hypertrophy is an important PTHrP-independent
function of IHH in vivo.8 Thus, in combination with the data from PTH1–34
treatments, our results demonstrate preservation in alginate culture of the
crucial functions that comprise the PTHrP-IHH signaling feedback loop, a
key node in the regulatory network of growth plate cartilage.2,5
Although treatment with IHH, PMA, or thyroxine resulted in similar effects
on chondrocyte hypertrophy, we observed one crucial difference—both IHH
and thryoxine treatments produced regional differences in chondrocyte
hypertrophy in alginate beads. Specifically, treatment with IHH or thyroxine
was sufficient to stratify alginate bead cultures into an inner core consisting
of nonhypertrophic (resting/proliferative) chondrocytes and an outer ring of
ColX-expressing hypertrophic chondrocytes, which mimics the layered
organization of growth plate cartilage in vivo.
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Regional differences were unexpected from treatment with a single factor,
but they could occur if diffusion of the hypertrophy-inducing factors into
the bead was rate limiting. Restricted diffusion of IHH might be expected
since the pore size in 1.5% alginate gels restricts the diffusion of molecules
in the 10–70 kD range to varying degrees37 and mature IHH protein has a
molecular mass of 20 kD. However, IHH is sufficiently small that it could
be expected to equilibrate in concentration throughout the bead during 4
days in culture,37 and, therefore, a distinction between the core and the
periphery should lessen over time. An additional argument against a
requirement for sustained exogenous concentration gradients is the
observation that the small molecule thyroxine also induced a hypertrophic
domain. Thyroxine has a negative charge that should limit interaction with
the alginate scaffold and a low molecular weight (0.78 kD) that should allow
unimpeded diffusion in alginate gels.52 Therefore, the current data do not
support a model in which sustained concentration gradients of signaling
molecules are required to establish zonal differences in growth plate
chondrocytes.
If not by sustained concentration gradients of exogenous signaling
molecules, what mechanism might account for regionalization of
chondrocytes in alginate beads? An alternative model is that a concentration
gradient is only transiently required to initiate the formation of distinct
maturation domains. In this context, the current results most likely indicate
induction of PTHrP expression in the nonhypertrophic core chondrocytes in
response to IHH produced by the peripheral hypertrophic chondrocytes (Fig.
7). In turn, endogenously produced PTHrP from the core chondrocytes
might diffuse toward the periphery, inhibiting IHH-dependent hypertrophy.
Consequently, an initial anisotropic growth factor stimulus can activate the
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endogenous IHH-PTHrP signaling feedback interaction that generates
distinct zones of chondrocyte maturation as observed in vivo.
View larger version
FIG. 7. Model exploring the potential mechanisms of IHH-driven
zonal demarcation. Possibilities include an outside-in IHH-diffusion
gradient (left) where cells that are exposed to high levels of IHH are
induced to hypertrophy, but at the center of the bead, cells are seeing
less IHH and maintain a static differentiation state. Alternatively, IHH diffuses into the
bead rapidly, creating a uniform IHH concentration in media (right). Under this model,
IHH induction of hypertrophy is balanced by endogenous PTHrP expression
(differentiation block). Since PTHrP rapidly diffuses out of alginate but is constantly
produced, this forms a radial gradient of PTHrP from the inside out where cells on the
outer ring are exposed to a higher IHH/PTHrP ratio, causing induction of hypertrophy.
Conclusion
Our results are the first demonstration of a tunable, 3D culture model of
growth plate cartilage. This culture system will be an important tool for
elucidating the mechanisms underlying chondrocyte differentiation,
cartilage architecture. In addition, our in vitro model could be used to
advance drug discovery by facilitating high-throughput screening for
molecules that regulate cartilage growth. Finally, our results encourage
future studies that aim at using alginate hydrogel scaffolds to engineer
cartilage constructs of defined proportions in vitro.
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Culture in alginate hydrogel promotes chondrocyte growth. (A) Invitrogen Live/Dead
assay to determine chondrocyte viability for at least a week of alginate culture.
Evident cell proliferation is noticed over time, but low amounts of dead cells are seen
at all time points (n = 3). (B) Immunofluorescence assay demonstrating the formation
of pericellular matrix in alginate culture using antibodies against Collagen IV (left)
and Collagen VI (right). Freshly isolated chondrocytes lack ECM staining, but they
produce de novo ECM after 1 day in alginate culture. On day 4 (right), a secondary
ECM structure is observed resembling territorial matrices (n = 4). Arrowheads in (B)







Culture in alginate hydrogel restrains cartilage differentiation. Gene expression
analysis of alginate cultures using ddPCR (n = 4) to count mRNA transcripts of
Collagen 2 (A), Collagen 1 (B), Collagen X (D), and PTHrP (F). Values are reported
as fold change in gene expression relative to day 1. (C) Ratio of mRNA transcript
counts of Collagen 2 and Collagen 1. (E) Propidium iodide cell cycle analysis by
FACS to quantify percentage of cells in S phase (DNA synthesis for cell
proliferation/growth). Alginate cultures tend to increase the number of proliferating
cells over time, compared with D0 and D1 (n = 3). *p < 0.05, **p < 0.01. ddPCR,






Treatment with PTH1–34 accelerates the chondrocyte response to alginate bead
culture. (A) Propidium iodide cell cycle analysis by FACS to quantify percentage of
cells in S phase (DNA synthesis for cell proliferation/growth). PTH treatment on day 1
stimulates proliferation similar to levels that are typically seen in day 4 cultures.
However, 4 days of PTH treatment has little effect (n = 4). (B–E) Gene expression
analysis was performed on PTH-treated alginate cultures with ddPCR to count
mRNA transcripts. On day 1 (left), PTHrP signaling inhibits expression of Collagen X
(B), IHH (C), and PTHrP (E), but not Collagen 2 (D). After 4 days of culture (right), the
effects of PTHrP on gene expression are greatly attenuated (n = 3). *p < 0.05, **p < 
37





Visualizing chondrocyte gene expression in alginate bead culture. (A) Fluorescent
images generated by using our improved protocol exploiting acrylamide embedding
of fixed beads in conjunction with fluorescent in situ hybridization (FISH) to visualize
cells that highly express Collagen II (left) and Collagen X (right) as a cell-by-cell
measure of hypertrophic differentiation. Images are analyzed via a fully automated
macro in ImageJ to quantify the percentage of cells expressing each gene relative to
a nuclear DAPI stain. Ratio of these percentages was calculated (ColX/Col2) to yield
a hypertrophic index (refer to Methods for more details). (B) Quantification of






Induction of hypertrophy after exogenous activation of IHH signaling. (A, B) Analysis
of FISH-derived images to calculate the extent of hypertrophy in alginate cultures
treated with thyroxine (10, 500 ng/mL), BMP4 (1, 5 ng/mL), PMA (0.5, 5 μg/mL), and
IHH (100 ng/mL) for a single day (A) and for 4 days in culture (B) (n = 3). In panel B,
PMA 20 day 4, the error bar is much larger than the rest of the data points and,
therefore, is clipped by the axis. (C, D) Propidium iodide analysis of stimulated bead
cultures was performed to quantify the percentage of cells in S phase (n = 3) on days






IHH treatment in alginate bead culture is sufficient to establish chondrocyte zonal
arrangement. (A) FISH (top) was used to visualize ColX-expressing (left) and ColII-
expressing (right) cells in 100 ng/mL IHH-treated cultures. White dotted lines
delineate the observed zones of predominant expression. Red dotted lines
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delineate the outer boundary of the bead. Beads form a ColX-enriched ring (outer
portion) surrounding a ColII-enriched core (inner portion). DAPI (middle) is shown
on the right to demonstrate that cells are still evenly dispersed in hydrogel culture
after 4 days, aside from isogenic groups, (n = 3). (B) Counts of ColII-expressing and
ColX-expressing cells (divided by the count of DAPI-positive nuclei in each FISH
image), stacked in a bar graph to illustrate the relative predominance of hypertrophic
versus nonhypertrophic chondrocytes in different domains of the IHH-treated alginate
beads. (C) Hypertrophic indexes of different domains of the IHH-treated alginate
beads. (D) FISH was used to visualize ColX-expressing (left) and total (right)





Model exploring the potential mechanisms of IHH-driven zonal demarcation.
Possibilities include an outside-in IHH-diffusion gradient (left) where cells that are
exposed to high levels of IHH are induced to hypertrophy, but at the center of the
bead, cells are seeing less IHH and maintain a static differentiation state.
Alternatively, IHH diffuses into the bead rapidly, creating a uniform IHH concentration
in media (right). Under this model, IHH induction of hypertrophy is balanced by
endogenous PTHrP expression (differentiation block). Since PTHrP rapidly diffuses
out of alginate but is constantly produced, this forms a radial gradient of PTHrP from
the inside out where cells on the outer ring are exposed to a higher IHH/PTHrP ratio,
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